BNP/CALL/ALCON AG/60/0.1/20.12.24 Stock

Warrant

DE000PN8TG09

Real-time Bid/Ask 08:31:22 2024-07-12 am EDT
2.25 EUR / 2.27 EUR +4.63% Intraday chart for BNP/CALL/ALCON AG/60/0.1/20.12.24
1 month-8.47%
3 months+24.14%
Date Price Change
24-07-12 2.28 +5.56%
24-07-11 2.16 +3.35%
24-07-10 2.09 -7.11%
24-07-09 2.25 +2.74%
24-07-08 2.19 -0.90%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 04:21 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN8TG0
ISINDE000PN8TG09
Date issued 2023-09-26
Strike 60 CHF
Maturity 2024-12-20 (161 Days)
Parity 10 : 1
Emission price 1.57
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.45
Lowest since issue 0.86
Spread 0.02
Spread %0.88%

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
90.38 USD
Average target price
93.95 USD
Spread / Average Target
+3.95%
Consensus